Literature DB >> 7667281

Retrograde axonal transport of glial cell line-derived neurotrophic factor in the adult nigrostriatal system suggests a trophic role in the adult.

A Tomac1, J Widenfalk, L F Lin, T Kohno, T Ebendal, B J Hoffer, L Olson.   

Abstract

The recently cloned, distant member of the transforming growth factor beta (TGF-beta) family, glial cell line-derived neurotrophic factor (GDNF), has potent trophic actions on fetal mesencephalic dopamine neurons. GDNF also has protective and restorative activity on adult mesencephalic dopaminergic neurons and potently protects motoneurons from axotomy-induced cell death. However, evidence for a role for endogenous GDNF as a target-derived trophic factor in adult midbrain dopaminergic circuits requires documentation of specific transport from the sites of synthesis in the target areas to the nerve cell bodies themselves. Here, we demonstrate that GDNF is retrogradely transported by mesencephalic dopamine neurons of the nigrostriatal pathway. The pattern of retrograde transport following intrastriatal injections indicates that there may be subpopulations of neurons that are GDNF responsive. Retrograde axonal transport of biologically active 125I-labeled GDNF was inhibited by an excess of unlabeled GDNF but not by an excess of cytochrome c. Specificity was further documented by demonstrating that another TGF-beta family member, TGF-beta 1, did not appear to affect retrograde transport. Retrograde transport was also demonstrated by immunohistochemistry by using intrastriatal injections of unlabeled GDNF. GDNF immunoreactivity was found specifically in dopamine nerve cell bodies of the substantia nigra pars compacta distributed in granules in the soma and proximal dendrites. Our data implicate a specific receptor-mediated uptake mechanism operating in the adult. Taken together, the present findings suggest that GDNF acts endogenously as a target-derived physiological survival/maintenance factor for dopaminergic neurons.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7667281      PMCID: PMC41139          DOI: 10.1073/pnas.92.18.8274

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Subdivisions of the dopamine-containing A8-A9-A10 complex identified by their differential mesostriatal innervation of striosomes and extrastriosomal matrix.

Authors:  J Jimenez-Castellanos; A M Graybiel
Journal:  Neuroscience       Date:  1987-10       Impact factor: 3.590

2.  Heterogeneity of striatal and limbic dopamine innervation: highly fluorescent islands in developing and adult rats.

Authors:  L Olson; A Seiger; K Fuxe
Journal:  Brain Res       Date:  1972-09-15       Impact factor: 3.252

3.  Correspondence between the dopamine islands and striosomes of the mammalian striatum.

Authors:  A M Graybiel
Journal:  Neuroscience       Date:  1984-12       Impact factor: 3.590

4.  Direct demonstration of a correspondence between the dopamine islands and acetylcholinesterase patches in the developing striatum.

Authors:  A M Graybiel; V M Pickel; T H Joh; D J Reis; C W Ragsdale
Journal:  Proc Natl Acad Sci U S A       Date:  1981-09       Impact factor: 11.205

5.  Compartmental organization of the mammalian striatum.

Authors:  A M Graybiel
Journal:  Prog Brain Res       Date:  1983       Impact factor: 2.453

6.  Intraputaminal infusion of nerve growth factor to support adrenal medullary autografts in Parkinson's disease. One-year follow-up of first clinical trial.

Authors:  L Olson; E O Backlund; T Ebendal; R Freedman; B Hamberger; P Hansson; B Hoffer; U Lindblom; B Meyerson; I Strömberg
Journal:  Arch Neurol       Date:  1991-04

7.  The neostriatal mosaic: compartmental distribution of calcium-binding protein and parvalbumin in the basal ganglia of the rat and monkey.

Authors:  C R Gerfen; K G Baimbridge; J J Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

8.  5'-nucleotidase: a new marker for striosomal organization in the rat caudoputamen.

Authors:  S W Schoen; A M Graybiel
Journal:  J Comp Neurol       Date:  1992-08-22       Impact factor: 3.215

9.  Brain-derived neurotrophic factor: subcellular compartmentalization and interneuronal transfer as visualized with anti-peptide antibodies.

Authors:  C Wetmore; Y H Cao; R F Pettersson; L Olson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

10.  GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo.

Authors:  C M Kearns; D M Gash
Journal:  Brain Res       Date:  1995-02-20       Impact factor: 3.252

View more
  56 in total

1.  GDNF protection against 6-OHDA: time dependence and requirement for protein synthesis.

Authors:  C M Kearns; W A Cass; K Smoot; R Kryscio; D M Gash
Journal:  J Neurosci       Date:  1997-09-15       Impact factor: 6.167

Review 2.  Synaptogenesis in the CNS: an odyssey from wiring together to firing together.

Authors:  David W Munno; Naweed I Syed
Journal:  J Physiol       Date:  2003-08-01       Impact factor: 5.182

3.  Nucleus accumbens-derived glial cell line-derived neurotrophic factor is a retrograde enhancer of dopaminergic tone in the mesocorticolimbic system.

Authors:  Jun Wang; Sebastien Carnicella; Somayeh Ahmadiantehrani; Dao-Yao He; Segev Barak; Viktor Kharazia; Sami Ben Hamida; Agustin Zapata; Toni S Shippenberg; Dorit Ron
Journal:  J Neurosci       Date:  2010-10-27       Impact factor: 6.167

Review 4.  Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa.

Authors:  Yoland Smith; Thomas Wichmann; Stewart A Factor; Mahlon R DeLong
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

5.  Endogenous GDNF in ventral tegmental area and nucleus accumbens does not play a role in the incubation of heroin craving.

Authors:  Mikko Airavaara; Charles L Pickens; Anna L Stern; Kristina A Wihbey; Brandon K Harvey; Jennifer M Bossert; Qing-Rong Liu; Barry J Hoffer; Yavin Shaham
Journal:  Addict Biol       Date:  2010-12-23       Impact factor: 4.280

6.  GDNF and alcohol use disorder.

Authors:  Segev Barak; Somayeh Ahmadiantehrani; Marian L Logrip; Dorit Ron
Journal:  Addict Biol       Date:  2018-05-04       Impact factor: 4.280

7.  Nigral GFRα1 infusion in aged rats increases locomotor activity, nigral tyrosine hydroxylase, and dopamine content in synchronicity.

Authors:  Brandon S Pruett; Michael F Salvatore
Journal:  Mol Neurobiol       Date:  2013-01-16       Impact factor: 5.590

8.  Neuroprotective potential of pleiotrophin overexpression in the striatonigral pathway compared with overexpression in both the striatonigral and nigrostriatal pathways.

Authors:  S E Gombash; F P Manfredsson; R J Mandel; T J Collier; D L Fischer; C J Kemp; N M Kuhn; S L Wohlgenant; S M Fleming; C E Sortwell
Journal:  Gene Ther       Date:  2014-05-08       Impact factor: 5.250

Review 9.  Neurotrophic factors for the investigation and treatment of movement disorders.

Authors:  Justo Garcia De Yébenes; Marina Sánchez; Maria Angeles Mena
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

10.  Glial cell line-derived neurotrophic factor requires transforming growth factor-beta for exerting its full neurotrophic potential on peripheral and CNS neurons.

Authors:  K Krieglstein; P Henheik; L Farkas; J Jaszai; D Galter; K Krohn; K Unsicker
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.